PP_July的个人主页 - 老虎社区

PP_July

PP_July

暂无个人介绍

IP属地：未知

9关注

0粉丝

0主题

0勋章

2021-12-07

Great

Alibaba stock jumped 7% in morning trading

2021-12-07

Interesting

Vaccine stocks mixed in morning trading

2021-11-26

Valuable info☺️

Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%

2021-11-25

Good

抱歉，原内容已删除

2021-11-24

[Heart]

抱歉，原内容已删除

2021-11-18

$Apple(AAPL)$[Cool]

2021-11-07

Interesting

Will Pfizer Outgun Merck With Oral COVID-19 Pill?

2021-11-03

$Moderna, Inc.(MRNA)$[Grin] [Cool]

2021-11-01

$Merck(MRK)$[Miser]

2021-10-26

$Apple(AAPL)$[Miser]

2021-10-20

$Aterian Inc.(ATER)$[Cool]

2021-10-19

$Netflix(NFLX)$[Cool]

2021-08-24

$Tiger Brokers(TIGR)$[Great]

2021-08-19

$Johnson & Johnson(JNJ)$[Miser]

2021-08-09

$Inari Medical, Inc.(NARI)$[Miser]

2021-08-04

$BioNTech SE(BNTX)$[Miser]

2021-08-02

$Pfizer(PFE)$[Smile]

2021-07-29

$Tesla Motors(TSLA)$[Miser]

2021-07-27

$Pfizer(PFE)$[Miser]

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4088337047102210","uuid":"4088337047102210","gmtCreate":1625658954380,"gmtModify":1706620620843,"name":"PP_July","pinyin":"ppjulyppjuly","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":9,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.70%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":606952221,"gmtCreate":1638827854949,"gmtModify":1638827854949,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606952221","repostId":"1151061798","repostType":4,"repost":{"id":"1151061798","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802296,"share":"https://www.laohu8.com/m/news/1151061798?lang=&edition=full","pubTime":"2021-12-06 22:51","market":"us","language":"en","title":"Alibaba stock jumped 7% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1151061798","media":"Tiger Newspress","summary":"Alibaba stock jumped 7% in morning trading afer the company overhauled e-commerce businesses and nam","content":"<p>Alibaba stock jumped&nbsp;7% in morning trading&nbsp;afer&nbsp;the&nbsp;company&nbsp;overhauled e-commerce businesses&nbsp;and&nbsp;named new CFO.</p>\n<p><img src=\"https://static.tigerbbs.com/0155455070ae9f5524078c679415af94\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>Alibaba Group Holding Ltd&nbsp;said it will reorganise its international and domestic e-commerce businesses and replace its CFO.</p>\n<p>It will form two new units - international digital commerce and China digital commerce which it said was part of efforts to become more agile and accelerate growth.</p>\n<p>The international digital commerce unit will include AliExpress which sells to retail buyers particularly in Europe and South America, its Southeast Asian e-commerce business Lazada and Alibaba.com which is more focused on selling to overseas business customers.</p>\n<p>It will be headed by Jiang Fan, who had been in charge of its main Chinese retail marketplaces, and the change is seen in line with Alibaba's aim to make 'globalisation' a key focus area in addition to cloud computing and domestic consumer spending.</p>\n<p>The China digital commerce unit will include Alibaba's two main marketplaces, Tmall for established brands and Taobao which welcomes all kinds of merchants. It will be led by Trudy Dai, who has previously overseen a number of Alibaba platforms.</p>\n<p>Alibaba also announced that deputy chief financial officer Toby Xu will succeed Maggie Wu as CFO from April, describing his appointment as part of the company's leadership succession plan. Xu joined Alibaba from PWC three years ago.</p>\n<p>Hit by weaker growth for the economy and fierce competition from a plethora of rivals, Alibaba last month slashed its&nbsp;forecast for annual revenue growth&nbsp;to its slowest pace since its 2014 stock market debut. It also saw sales at its banner event, online shopping festival Singles Day, grow at&nbsp;their slowest rate ever.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba stock jumped 7% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba stock jumped 7% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alibaba stock jumped&nbsp;7% in morning trading&nbsp;afer&nbsp;the&nbsp;company&nbsp;overhauled e-commerce businesses&nbsp;and&nbsp;named new CFO.</p>\n<p><img src=\"https://static.tigerbbs.com/0155455070ae9f5524078c679415af94\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>Alibaba Group Holding Ltd&nbsp;said it will reorganise its international and domestic e-commerce businesses and replace its CFO.</p>\n<p>It will form two new units - international digital commerce and China digital commerce which it said was part of efforts to become more agile and accelerate growth.</p>\n<p>The international digital commerce unit will include AliExpress which sells to retail buyers particularly in Europe and South America, its Southeast Asian e-commerce business Lazada and Alibaba.com which is more focused on selling to overseas business customers.</p>\n<p>It will be headed by Jiang Fan, who had been in charge of its main Chinese retail marketplaces, and the change is seen in line with Alibaba's aim to make 'globalisation' a key focus area in addition to cloud computing and domestic consumer spending.</p>\n<p>The China digital commerce unit will include Alibaba's two main marketplaces, Tmall for established brands and Taobao which welcomes all kinds of merchants. It will be led by Trudy Dai, who has previously overseen a number of Alibaba platforms.</p>\n<p>Alibaba also announced that deputy chief financial officer Toby Xu will succeed Maggie Wu as CFO from April, describing his appointment as part of the company's leadership succession plan. Xu joined Alibaba from PWC three years ago.</p>\n<p>Hit by weaker growth for the economy and fierce competition from a plethora of rivals, Alibaba last month slashed its&nbsp;forecast for annual revenue growth&nbsp;to its slowest pace since its 2014 stock market debut. It also saw sales at its banner event, online shopping festival Singles Day, grow at&nbsp;their slowest rate ever.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151061798","content_text":"Alibaba stock jumped 7% in morning trading afer the company overhauled e-commerce businesses and named new CFO.\n\nAlibaba Group Holding Ltd said it will reorganise its international and domestic e-commerce businesses and replace its CFO.\nIt will form two new units - international digital commerce and China digital commerce which it said was part of efforts to become more agile and accelerate growth.\nThe international digital commerce unit will include AliExpress which sells to retail buyers particularly in Europe and South America, its Southeast Asian e-commerce business Lazada and Alibaba.com which is more focused on selling to overseas business customers.\nIt will be headed by Jiang Fan, who had been in charge of its main Chinese retail marketplaces, and the change is seen in line with Alibaba's aim to make 'globalisation' a key focus area in addition to cloud computing and domestic consumer spending.\nThe China digital commerce unit will include Alibaba's two main marketplaces, Tmall for established brands and Taobao which welcomes all kinds of merchants. It will be led by Trudy Dai, who has previously overseen a number of Alibaba platforms.\nAlibaba also announced that deputy chief financial officer Toby Xu will succeed Maggie Wu as CFO from April, describing his appointment as part of the company's leadership succession plan. Xu joined Alibaba from PWC three years ago.\nHit by weaker growth for the economy and fierce competition from a plethora of rivals, Alibaba last month slashed its forecast for annual revenue growth to its slowest pace since its 2014 stock market debut. It also saw sales at its banner event, online shopping festival Singles Day, grow at their slowest rate ever.","news_type":1},"isVote":1,"tweetType":1,"viewCount":679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606956787,"gmtCreate":1638827738103,"gmtModify":1638827738103,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606956787","repostId":"1172118771","repostType":4,"repost":{"id":"1172118771","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638803122,"share":"https://www.laohu8.com/m/news/1172118771?lang=&edition=full","pubTime":"2021-12-06 23:05","market":"us","language":"en","title":"Vaccine stocks mixed in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1172118771","media":"Tiger Newspress","summary":"Vaccine stocks mixed in morning trading.Moderna and BioNTech SE plunged more than 12% while Johnson ","content":"<p>Vaccine&nbsp;stocks&nbsp;mixed&nbsp;in&nbsp;morning&nbsp;trading.Moderna and BioNTech SE plunged more than 12% while Johnson &amp; Johnson and&nbsp;AstraZeneca&nbsp;rose&nbsp;about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/a026a8b3f73899e06c8e4913061f6618\" tg-width=\"410\" tg-height=\"722\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks mixed in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks mixed in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 23:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;mixed&nbsp;in&nbsp;morning&nbsp;trading.Moderna and BioNTech SE plunged more than 12% while Johnson &amp; Johnson and&nbsp;AstraZeneca&nbsp;rose&nbsp;about 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/a026a8b3f73899e06c8e4913061f6618\" tg-width=\"410\" tg-height=\"722\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNY":"赛诺菲安万特","PFE":"辉瑞","REGN":"再生元制药公司","MRNA":"Moderna, Inc.","MRK":"默沙东","BNTX":"BioNTech SE","JNJ":"强生","LLY":"礼来","GSK":"葛兰素史克","GILD":"吉利德科学"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172118771","content_text":"Vaccine stocks mixed in morning trading.Moderna and BioNTech SE plunged more than 12% while Johnson & Johnson and AstraZeneca rose about 2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":815,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877668648,"gmtCreate":1637925815543,"gmtModify":1637925831049,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Valuable info☺️","listText":"Valuable info☺️","text":"Valuable info☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877668648","repostId":"1154704265","repostType":4,"repost":{"id":"1154704265","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637917480,"share":"https://www.laohu8.com/m/news/1154704265?lang=&edition=full","pubTime":"2021-11-26 17:04","market":"us","language":"en","title":"Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154704265","media":"Tiger Newspress","summary":"Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%.\nA","content":"<p>Vaccine&nbsp;stocks&nbsp;gained&nbsp;in&nbsp;premarket&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;7%&nbsp;and&nbsp;BioNTech&nbsp;rose&nbsp;5%.</p>\n<p><img src=\"https://static.tigerbbs.com/2206f2ee0001e7351cd413c669b8f064\" tg-width=\"880\" tg-height=\"633\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/aaa14458d374d03a163e350ce25d7dc9\" tg-width=\"873\" tg-height=\"636\" referrerpolicy=\"no-referrer\">A new variant of the coronavirus that causes Covid-19 -- called B.1.1.529 -- has been identified in South Africa, with officials there saying it’s of concern. Fears a new strain could fuel outbreaks in many countries, straining health systems, potentially evading vaccines and complicating efforts to reopen economies and borders, sent a wave of risk aversion across global markets Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;gained&nbsp;in&nbsp;premarket&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;7%&nbsp;and&nbsp;BioNTech&nbsp;rose&nbsp;5%.</p>\n<p><img src=\"https://static.tigerbbs.com/2206f2ee0001e7351cd413c669b8f064\" tg-width=\"880\" tg-height=\"633\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/aaa14458d374d03a163e350ce25d7dc9\" tg-width=\"873\" tg-height=\"636\" referrerpolicy=\"no-referrer\">A new variant of the coronavirus that causes Covid-19 -- called B.1.1.529 -- has been identified in South Africa, with officials there saying it’s of concern. Fears a new strain could fuel outbreaks in many countries, straining health systems, potentially evading vaccines and complicating efforts to reopen economies and borders, sent a wave of risk aversion across global markets Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154704265","content_text":"Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%.\nA new variant of the coronavirus that causes Covid-19 -- called B.1.1.529 -- has been identified in South Africa, with officials there saying it’s of concern. Fears a new strain could fuel outbreaks in many countries, straining health systems, potentially evading vaccines and complicating efforts to reopen economies and borders, sent a wave of risk aversion across global markets Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874456978,"gmtCreate":1637814811694,"gmtModify":1637814811694,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874456978","repostId":"1137701323","repostType":4,"isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874854546,"gmtCreate":1637761840836,"gmtModify":1637761840836,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"[Heart]&nbsp;","listText":"[Heart]&nbsp;","text":"[Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874854546","repostId":"2185804343","repostType":2,"isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878855888,"gmtCreate":1637171519642,"gmtModify":1637171519707,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Cool]&nbsp;","text":"$Apple(AAPL)$[Cool]","images":[{"img":"https://static.tigerbbs.com/8946805703cdc51ec4de3e46b2773836","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878855888","isVote":1,"tweetType":1,"viewCount":1031,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845318009,"gmtCreate":1636282259289,"gmtModify":1636282259361,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845318009","repostId":"1152406340","repostType":4,"repost":{"id":"1152406340","pubTimestamp":1636157546,"share":"https://www.laohu8.com/m/news/1152406340?lang=&edition=full","pubTime":"2021-11-06 08:12","market":"us","language":"en","title":"Will Pfizer Outgun Merck With Oral COVID-19 Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1152406340","media":"Benzinga","summary":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy ","content":"<p><b>Merck, Inc.</b>&nbsp;is locking horns with peer&nbsp;<b>Pfizer, Inc.</b>&nbsp;in what could be termed as the battle supremacy in the COVID-19 treatment market.</p>\n<p>The stakes are high, with&nbsp;an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.</p>\n<p><b>Pfizer Dips Into COVID-19 Treatment Arena:</b>After acing the&nbsp;COVID-19 vaccine race&nbsp;along with its German partner&nbsp;<b>BioNTech SE</b>, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.</p>\n<p>The company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.</p>\n<p>The positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.</p>\n<p>Merck had its share of upside in early October when it reported positive Phase 3 data for an&nbsp;oral COVID-19 pill,&nbsp;molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.</p>\n<p>These two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.</p>\n<p><b>Pfizer Vs. Merck Data Comparison:</b>As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.</p>\n<p>Only about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.</p>\n<p>Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.</p>\n<p>Merck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.</p>\n<p>Through day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight&nbsp;deaths in patients who received placebo.</p>\n<p>Not only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.</p>\n<p>\"Between&nbsp;<b>Roche Holding AG's</b>&nbsp;recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.</p>\n<p><b>Authorization Before Year-End?</b>At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.</p>\n<p>It plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.</p>\n<p>BofA expects the application to be soon submitted to the FDA, with&nbsp;an authorization likely&nbsp;by the end of the year.</p>\n<p>Meanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.</p>\n<p>Its application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.</p>\n<p>The commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.</p>\n<p>Meanwhile,&nbsp;<b>Gilead, Inc.'s</b>&nbsp;antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.</p>\n<p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Pfizer Outgun Merck With Oral COVID-19 Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Pfizer Outgun Merck With Oral COVID-19 Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 08:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152406340","content_text":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.\nPfizer Dips Into COVID-19 Treatment Arena:After acing the COVID-19 vaccine race along with its German partner BioNTech SE, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.\nThe company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.\nThe positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.\nMerck had its share of upside in early October when it reported positive Phase 3 data for an oral COVID-19 pill, molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.\nThese two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.\nPfizer Vs. Merck Data Comparison:As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.\nOnly about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.\nSimilar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.\nMerck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.\nThrough day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo.\nNot only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.\n\"Between Roche Holding AG's recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.\nAuthorization Before Year-End?At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.\nIt plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.\nBofA expects the application to be soon submitted to the FDA, with an authorization likely by the end of the year.\nMeanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.\nIts application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.\nThe commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.\nMeanwhile, Gilead, Inc.'s antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.","news_type":1},"isVote":1,"tweetType":1,"viewCount":926,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841710813,"gmtCreate":1635942132585,"gmtModify":1635942345893,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Grin]&nbsp;[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Grin]&nbsp;[Cool]&nbsp;","text":"$Moderna, Inc.(MRNA)$[Grin] [Cool]","images":[{"img":"https://static.tigerbbs.com/cfac3d57c88639385c9ec576f3abff13","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841710813","isVote":1,"tweetType":1,"viewCount":1073,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849595820,"gmtCreate":1635764533471,"gmtModify":1635764533471,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>[Miser]&nbsp;","text":"$Merck(MRK)$[Miser]","images":[{"img":"https://static.tigerbbs.com/4731e1124d23dd6dbf40f6112c0fdb03","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849595820","isVote":1,"tweetType":1,"viewCount":727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":852143881,"gmtCreate":1635255500813,"gmtModify":1635255500926,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Miser]&nbsp;","text":"$Apple(AAPL)$[Miser]","images":[{"img":"https://static.tigerbbs.com/514007d28a9428696b15cb3cc055cc9f","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852143881","isVote":1,"tweetType":1,"viewCount":863,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":859703479,"gmtCreate":1634729963066,"gmtModify":1634729963155,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Cool]&nbsp;","text":"$Aterian Inc.(ATER)$[Cool]","images":[{"img":"https://static.tigerbbs.com/e948df862e9ab84f5f8d5d5fb5841e45","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859703479","isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":859041055,"gmtCreate":1634644455710,"gmtModify":1634644455875,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NFLX\">$Netflix(NFLX)$</a>[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/NFLX\">$Netflix(NFLX)$</a>[Cool]&nbsp;","text":"$Netflix(NFLX)$[Cool]","images":[{"img":"https://static.tigerbbs.com/81c6da67fb7138c034062f1c3811bc0c","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859041055","isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":834596509,"gmtCreate":1629812246201,"gmtModify":1631891495202,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Great]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Great]&nbsp;","text":"$Tiger Brokers(TIGR)$[Great]","images":[{"img":"https://static.tigerbbs.com/6e6b91df25f14243402ce4568f818786","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834596509","isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":838175937,"gmtCreate":1629383149829,"gmtModify":1631886967717,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JNJ\">$Johnson &amp; Johnson(JNJ)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/JNJ\">$Johnson &amp; Johnson(JNJ)$</a>[Miser]&nbsp;","text":"$Johnson & Johnson(JNJ)$[Miser]","images":[{"img":"https://static.tigerbbs.com/98019dcdc702cafb7bfac8210c2c76b2","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/838175937","isVote":1,"tweetType":1,"viewCount":4,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898433977,"gmtCreate":1628516528699,"gmtModify":1631888778662,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NARI\">$Inari Medical, Inc.(NARI)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/NARI\">$Inari Medical, Inc.(NARI)$</a>[Miser]&nbsp;","text":"$Inari Medical, Inc.(NARI)$[Miser]","images":[{"img":"https://static.tigerbbs.com/d5f3698de05fee1af270cc9aa1ab9956","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/898433977","isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890907289,"gmtCreate":1628072908241,"gmtModify":1631883899533,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>[Miser]&nbsp;","text":"$BioNTech SE(BNTX)$[Miser]","images":[{"img":"https://static.tigerbbs.com/73629c85ba1843a11ec24aafd597d7aa","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890907289","isVote":1,"tweetType":1,"viewCount":18,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805752980,"gmtCreate":1627909265740,"gmtModify":1631891495212,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Smile]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Smile]&nbsp;","text":"$Pfizer(PFE)$[Smile]","images":[{"img":"https://static.tigerbbs.com/001e1eb2c168908468cd4820140334a2","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805752980","isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808609734,"gmtCreate":1627571360128,"gmtModify":1631891495214,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[Miser]&nbsp;","text":"$Tesla Motors(TSLA)$[Miser]","images":[{"img":"https://static.tigerbbs.com/f428d9278ffe82b1a06388fe18a7c3ab","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808609734","isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":809479394,"gmtCreate":1627390541218,"gmtModify":1631891495214,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Miser]&nbsp;","text":"$Pfizer(PFE)$[Miser]","images":[{"img":"https://static.tigerbbs.com/6a8e8ecfea57fdd4e56a75e09a5e7dcd","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/809479394","isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":606952221,"gmtCreate":1638827854949,"gmtModify":1638827854949,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606952221","repostId":"1151061798","repostType":4,"repost":{"id":"1151061798","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802296,"share":"https://www.laohu8.com/m/news/1151061798?lang=&edition=full","pubTime":"2021-12-06 22:51","market":"us","language":"en","title":"Alibaba stock jumped 7% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1151061798","media":"Tiger Newspress","summary":"Alibaba stock jumped 7% in morning trading afer the company overhauled e-commerce businesses and nam","content":"<p>Alibaba stock jumped&nbsp;7% in morning trading&nbsp;afer&nbsp;the&nbsp;company&nbsp;overhauled e-commerce businesses&nbsp;and&nbsp;named new CFO.</p>\n<p><img src=\"https://static.tigerbbs.com/0155455070ae9f5524078c679415af94\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>Alibaba Group Holding Ltd&nbsp;said it will reorganise its international and domestic e-commerce businesses and replace its CFO.</p>\n<p>It will form two new units - international digital commerce and China digital commerce which it said was part of efforts to become more agile and accelerate growth.</p>\n<p>The international digital commerce unit will include AliExpress which sells to retail buyers particularly in Europe and South America, its Southeast Asian e-commerce business Lazada and Alibaba.com which is more focused on selling to overseas business customers.</p>\n<p>It will be headed by Jiang Fan, who had been in charge of its main Chinese retail marketplaces, and the change is seen in line with Alibaba's aim to make 'globalisation' a key focus area in addition to cloud computing and domestic consumer spending.</p>\n<p>The China digital commerce unit will include Alibaba's two main marketplaces, Tmall for established brands and Taobao which welcomes all kinds of merchants. It will be led by Trudy Dai, who has previously overseen a number of Alibaba platforms.</p>\n<p>Alibaba also announced that deputy chief financial officer Toby Xu will succeed Maggie Wu as CFO from April, describing his appointment as part of the company's leadership succession plan. Xu joined Alibaba from PWC three years ago.</p>\n<p>Hit by weaker growth for the economy and fierce competition from a plethora of rivals, Alibaba last month slashed its&nbsp;forecast for annual revenue growth&nbsp;to its slowest pace since its 2014 stock market debut. It also saw sales at its banner event, online shopping festival Singles Day, grow at&nbsp;their slowest rate ever.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba stock jumped 7% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba stock jumped 7% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alibaba stock jumped&nbsp;7% in morning trading&nbsp;afer&nbsp;the&nbsp;company&nbsp;overhauled e-commerce businesses&nbsp;and&nbsp;named new CFO.</p>\n<p><img src=\"https://static.tigerbbs.com/0155455070ae9f5524078c679415af94\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>Alibaba Group Holding Ltd&nbsp;said it will reorganise its international and domestic e-commerce businesses and replace its CFO.</p>\n<p>It will form two new units - international digital commerce and China digital commerce which it said was part of efforts to become more agile and accelerate growth.</p>\n<p>The international digital commerce unit will include AliExpress which sells to retail buyers particularly in Europe and South America, its Southeast Asian e-commerce business Lazada and Alibaba.com which is more focused on selling to overseas business customers.</p>\n<p>It will be headed by Jiang Fan, who had been in charge of its main Chinese retail marketplaces, and the change is seen in line with Alibaba's aim to make 'globalisation' a key focus area in addition to cloud computing and domestic consumer spending.</p>\n<p>The China digital commerce unit will include Alibaba's two main marketplaces, Tmall for established brands and Taobao which welcomes all kinds of merchants. It will be led by Trudy Dai, who has previously overseen a number of Alibaba platforms.</p>\n<p>Alibaba also announced that deputy chief financial officer Toby Xu will succeed Maggie Wu as CFO from April, describing his appointment as part of the company's leadership succession plan. Xu joined Alibaba from PWC three years ago.</p>\n<p>Hit by weaker growth for the economy and fierce competition from a plethora of rivals, Alibaba last month slashed its&nbsp;forecast for annual revenue growth&nbsp;to its slowest pace since its 2014 stock market debut. It also saw sales at its banner event, online shopping festival Singles Day, grow at&nbsp;their slowest rate ever.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151061798","content_text":"Alibaba stock jumped 7% in morning trading afer the company overhauled e-commerce businesses and named new CFO.\n\nAlibaba Group Holding Ltd said it will reorganise its international and domestic e-commerce businesses and replace its CFO.\nIt will form two new units - international digital commerce and China digital commerce which it said was part of efforts to become more agile and accelerate growth.\nThe international digital commerce unit will include AliExpress which sells to retail buyers particularly in Europe and South America, its Southeast Asian e-commerce business Lazada and Alibaba.com which is more focused on selling to overseas business customers.\nIt will be headed by Jiang Fan, who had been in charge of its main Chinese retail marketplaces, and the change is seen in line with Alibaba's aim to make 'globalisation' a key focus area in addition to cloud computing and domestic consumer spending.\nThe China digital commerce unit will include Alibaba's two main marketplaces, Tmall for established brands and Taobao which welcomes all kinds of merchants. It will be led by Trudy Dai, who has previously overseen a number of Alibaba platforms.\nAlibaba also announced that deputy chief financial officer Toby Xu will succeed Maggie Wu as CFO from April, describing his appointment as part of the company's leadership succession plan. Xu joined Alibaba from PWC three years ago.\nHit by weaker growth for the economy and fierce competition from a plethora of rivals, Alibaba last month slashed its forecast for annual revenue growth to its slowest pace since its 2014 stock market debut. It also saw sales at its banner event, online shopping festival Singles Day, grow at their slowest rate ever.","news_type":1},"isVote":1,"tweetType":1,"viewCount":679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878855888,"gmtCreate":1637171519642,"gmtModify":1637171519707,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Cool]&nbsp;","text":"$Apple(AAPL)$[Cool]","images":[{"img":"https://static.tigerbbs.com/8946805703cdc51ec4de3e46b2773836","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878855888","isVote":1,"tweetType":1,"viewCount":1031,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":834596509,"gmtCreate":1629812246201,"gmtModify":1631891495202,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Great]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Great]&nbsp;","text":"$Tiger Brokers(TIGR)$[Great]","images":[{"img":"https://static.tigerbbs.com/6e6b91df25f14243402ce4568f818786","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834596509","isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":809479394,"gmtCreate":1627390541218,"gmtModify":1631891495214,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Miser]&nbsp;","text":"$Pfizer(PFE)$[Miser]","images":[{"img":"https://static.tigerbbs.com/6a8e8ecfea57fdd4e56a75e09a5e7dcd","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/809479394","isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890907289,"gmtCreate":1628072908241,"gmtModify":1631883899533,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>[Miser]&nbsp;","text":"$BioNTech SE(BNTX)$[Miser]","images":[{"img":"https://static.tigerbbs.com/73629c85ba1843a11ec24aafd597d7aa","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890907289","isVote":1,"tweetType":1,"viewCount":18,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":874456978,"gmtCreate":1637814811694,"gmtModify":1637814811694,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874456978","repostId":"1137701323","repostType":4,"repost":{"id":"1137701323","pubTimestamp":1637806144,"share":"https://www.laohu8.com/m/news/1137701323?lang=&edition=full","pubTime":"2021-11-25 10:09","market":"us","language":"en","title":"3 Dirt Cheap Stocks That Could Skyrocket","url":"https://stock-news.laohu8.com/highlight/detail?id=1137701323","media":"Motley Fool","summary":"Stocks aren't cheap by most gauges these days, but it doesn't mean that there aren't bargains to be ","content":"<p>Stocks aren't cheap by most gauges these days, but it doesn't mean that there aren't bargains to be had.<b>Walmart</b>(NYSE:WMT),<b>Walt Disney</b>(NYSE:DIS), and&nbsp;<b>Sirius XM Holdings</b>(NASDAQ:SIRI)are some of the stocks trading at depressed levels right now.</p>\n<p>They are blue chip bargains, something that we're not seeing a lot of with the market soaring this year. Let's take a closer look at what makes these dirt cheap stocks that could skyrocket.</p>\n<p>1. Walmart</p>\n<p>The country's largest retailer is a surprising laggard this year. Walmart shares are up a mere 2% in 2021 despite strong sales that jibe with the overall buoyant economy. The chain has prospered through the pandemic, and its Sam's Club warehouse club concept is faring even better.</p>\n<p>It's hard to find the flaws in the mass market discounter that Sam Walton built. It has easily exceeded Wall Street profit targets through its first three quarters of fiscal 2022. Comps rose 9.2% in its latest quarter. We're seeing strong year-over-year store-level comparisons from chains that were depressed last year, but that's not Walmart. It was growing nicely last year, too, and its two-year comps stack is up a hearty 15.6%.</p>\n<p>Walmart raised its guidance when it reported fresh financials last week. It now expects to post an adjusted profit of $6.40 a share for the fiscal year it will wrap up at the end of January. Walmart at 23 times this year's projected earnings may not seem cheap, but with fast-growing e-commerce, grocery delivery, and curbside pick-up businesses thriving Walmart deserves a market premium. The 1.5% dividend yield -- coming from aDividend Aristocratwith 48 years of payout hikes -- is the cherry on top in this climate of low interest rates.</p>\n<p>2. Walt Disney</p>\n<p>The House of Mouse is another name that may not seem cheap going by historical profit multiples. Even if we go out to the next fiscal year to see Disney deeper into its turnaround, the stock is trading at 30 times that year's profit target.</p>\n<p>Disney is another surprising slowpoke in 2021. It's the largest U.S. company to be trading more than 10% lower this year. A lot has gone right for Disney this year as the economy starts to reopen. Its theme parks are profitable again. Its cruise ships are sailing again. It's putting out the biggest movies of the year now that multiplexes are starting to get busy again.</p>\n<p>What is holding the stock back? Well, Disney+ is keeping the media giant from risingin more ways than one. The stock has been weak as Disney+ subscriber counts areslowing, and since the business isn't expected to be profitable until 2024 it's a drag on the family entertainment behemoth's bottom line. It's not fair to penalize Disney for the upstart costs of a bar-raising platform that has made it a major player in the booming streaming space. Disney is cheaper than the headline valuation metrics seem to suggest.</p>\n<p>3. Sirius XM Holdings</p>\n<p>Let's pump up the volume on the last pick. Sirius XM Holdings -- like Disney -- is another surprising stock that is trading lower this year. The country's only provider of satellite radio services is benefiting from folks driving again.</p>\n<p>A dozen years ago Sirius XM was on the brink of bankruptcy, but now it's a thriving platform generating gobs of free cash flow that it uses to buy back stock and reward investors with a growing quarterly dividend. The stock is now fetching less than 20 times this year's projected earnings, and between its namesake satellite radio monopoly and its Pandora streaming service it has a firm grasp on audiophiles no matter where they roam.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dirt Cheap Stocks That Could Skyrocket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dirt Cheap Stocks That Could Skyrocket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 10:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/24/3-dirt-cheap-stocks-that-could-skyrocket/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks aren't cheap by most gauges these days, but it doesn't mean that there aren't bargains to be had.Walmart(NYSE:WMT),Walt Disney(NYSE:DIS), and Sirius XM Holdings(NASDAQ:SIRI)are some of the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/24/3-dirt-cheap-stocks-that-could-skyrocket/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","WMT":"沃尔玛","SIRI":"Sirius XM Holdings Inc."},"source_url":"https://www.fool.com/investing/2021/11/24/3-dirt-cheap-stocks-that-could-skyrocket/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137701323","content_text":"Stocks aren't cheap by most gauges these days, but it doesn't mean that there aren't bargains to be had.Walmart(NYSE:WMT),Walt Disney(NYSE:DIS), and Sirius XM Holdings(NASDAQ:SIRI)are some of the stocks trading at depressed levels right now.\nThey are blue chip bargains, something that we're not seeing a lot of with the market soaring this year. Let's take a closer look at what makes these dirt cheap stocks that could skyrocket.\n1. Walmart\nThe country's largest retailer is a surprising laggard this year. Walmart shares are up a mere 2% in 2021 despite strong sales that jibe with the overall buoyant economy. The chain has prospered through the pandemic, and its Sam's Club warehouse club concept is faring even better.\nIt's hard to find the flaws in the mass market discounter that Sam Walton built. It has easily exceeded Wall Street profit targets through its first three quarters of fiscal 2022. Comps rose 9.2% in its latest quarter. We're seeing strong year-over-year store-level comparisons from chains that were depressed last year, but that's not Walmart. It was growing nicely last year, too, and its two-year comps stack is up a hearty 15.6%.\nWalmart raised its guidance when it reported fresh financials last week. It now expects to post an adjusted profit of $6.40 a share for the fiscal year it will wrap up at the end of January. Walmart at 23 times this year's projected earnings may not seem cheap, but with fast-growing e-commerce, grocery delivery, and curbside pick-up businesses thriving Walmart deserves a market premium. The 1.5% dividend yield -- coming from aDividend Aristocratwith 48 years of payout hikes -- is the cherry on top in this climate of low interest rates.\n2. Walt Disney\nThe House of Mouse is another name that may not seem cheap going by historical profit multiples. Even if we go out to the next fiscal year to see Disney deeper into its turnaround, the stock is trading at 30 times that year's profit target.\nDisney is another surprising slowpoke in 2021. It's the largest U.S. company to be trading more than 10% lower this year. A lot has gone right for Disney this year as the economy starts to reopen. Its theme parks are profitable again. Its cruise ships are sailing again. It's putting out the biggest movies of the year now that multiplexes are starting to get busy again.\nWhat is holding the stock back? Well, Disney+ is keeping the media giant from risingin more ways than one. The stock has been weak as Disney+ subscriber counts areslowing, and since the business isn't expected to be profitable until 2024 it's a drag on the family entertainment behemoth's bottom line. It's not fair to penalize Disney for the upstart costs of a bar-raising platform that has made it a major player in the booming streaming space. Disney is cheaper than the headline valuation metrics seem to suggest.\n3. Sirius XM Holdings\nLet's pump up the volume on the last pick. Sirius XM Holdings -- like Disney -- is another surprising stock that is trading lower this year. The country's only provider of satellite radio services is benefiting from folks driving again.\nA dozen years ago Sirius XM was on the brink of bankruptcy, but now it's a thriving platform generating gobs of free cash flow that it uses to buy back stock and reward investors with a growing quarterly dividend. The stock is now fetching less than 20 times this year's projected earnings, and between its namesake satellite radio monopoly and its Pandora streaming service it has a firm grasp on audiophiles no matter where they roam.","news_type":1},"isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859703479,"gmtCreate":1634729963066,"gmtModify":1634729963155,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>[Cool]&nbsp;","text":"$Aterian Inc.(ATER)$[Cool]","images":[{"img":"https://static.tigerbbs.com/e948df862e9ab84f5f8d5d5fb5841e45","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859703479","isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":805752980,"gmtCreate":1627909265740,"gmtModify":1631891495212,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Smile]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>[Smile]&nbsp;","text":"$Pfizer(PFE)$[Smile]","images":[{"img":"https://static.tigerbbs.com/001e1eb2c168908468cd4820140334a2","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805752980","isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808609734,"gmtCreate":1627571360128,"gmtModify":1631891495214,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>[Miser]&nbsp;","text":"$Tesla Motors(TSLA)$[Miser]","images":[{"img":"https://static.tigerbbs.com/f428d9278ffe82b1a06388fe18a7c3ab","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808609734","isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":606956787,"gmtCreate":1638827738103,"gmtModify":1638827738103,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606956787","repostId":"1172118771","repostType":4,"isVote":1,"tweetType":1,"viewCount":815,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877668648,"gmtCreate":1637925815543,"gmtModify":1637925831049,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Valuable info☺️","listText":"Valuable info☺️","text":"Valuable info☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877668648","repostId":"1154704265","repostType":4,"isVote":1,"tweetType":1,"viewCount":1143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874854546,"gmtCreate":1637761840836,"gmtModify":1637761840836,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"[Heart]&nbsp;","listText":"[Heart]&nbsp;","text":"[Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874854546","repostId":"2185804343","repostType":2,"isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845318009,"gmtCreate":1636282259289,"gmtModify":1636282259361,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845318009","repostId":"1152406340","repostType":4,"repost":{"id":"1152406340","pubTimestamp":1636157546,"share":"https://www.laohu8.com/m/news/1152406340?lang=&edition=full","pubTime":"2021-11-06 08:12","market":"us","language":"en","title":"Will Pfizer Outgun Merck With Oral COVID-19 Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1152406340","media":"Benzinga","summary":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy ","content":"<p><b>Merck, Inc.</b>&nbsp;is locking horns with peer&nbsp;<b>Pfizer, Inc.</b>&nbsp;in what could be termed as the battle supremacy in the COVID-19 treatment market.</p>\n<p>The stakes are high, with&nbsp;an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.</p>\n<p><b>Pfizer Dips Into COVID-19 Treatment Arena:</b>After acing the&nbsp;COVID-19 vaccine race&nbsp;along with its German partner&nbsp;<b>BioNTech SE</b>, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.</p>\n<p>The company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.</p>\n<p>The positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.</p>\n<p>Merck had its share of upside in early October when it reported positive Phase 3 data for an&nbsp;oral COVID-19 pill,&nbsp;molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.</p>\n<p>These two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.</p>\n<p><b>Pfizer Vs. Merck Data Comparison:</b>As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.</p>\n<p>Only about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.</p>\n<p>Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.</p>\n<p>Merck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.</p>\n<p>Through day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight&nbsp;deaths in patients who received placebo.</p>\n<p>Not only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.</p>\n<p>\"Between&nbsp;<b>Roche Holding AG's</b>&nbsp;recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.</p>\n<p><b>Authorization Before Year-End?</b>At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.</p>\n<p>It plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.</p>\n<p>BofA expects the application to be soon submitted to the FDA, with&nbsp;an authorization likely&nbsp;by the end of the year.</p>\n<p>Meanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.</p>\n<p>Its application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.</p>\n<p>The commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.</p>\n<p>Meanwhile,&nbsp;<b>Gilead, Inc.'s</b>&nbsp;antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.</p>\n<p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Pfizer Outgun Merck With Oral COVID-19 Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Pfizer Outgun Merck With Oral COVID-19 Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 08:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152406340","content_text":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.\nPfizer Dips Into COVID-19 Treatment Arena:After acing the COVID-19 vaccine race along with its German partner BioNTech SE, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.\nThe company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.\nThe positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.\nMerck had its share of upside in early October when it reported positive Phase 3 data for an oral COVID-19 pill, molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.\nThese two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.\nPfizer Vs. Merck Data Comparison:As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.\nOnly about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.\nSimilar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.\nMerck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.\nThrough day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo.\nNot only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.\n\"Between Roche Holding AG's recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.\nAuthorization Before Year-End?At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.\nIt plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.\nBofA expects the application to be soon submitted to the FDA, with an authorization likely by the end of the year.\nMeanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.\nIts application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.\nThe commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.\nMeanwhile, Gilead, Inc.'s antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.","news_type":1},"isVote":1,"tweetType":1,"viewCount":926,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841710813,"gmtCreate":1635942132585,"gmtModify":1635942345893,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Grin]&nbsp;[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Grin]&nbsp;[Cool]&nbsp;","text":"$Moderna, Inc.(MRNA)$[Grin] [Cool]","images":[{"img":"https://static.tigerbbs.com/cfac3d57c88639385c9ec576f3abff13","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841710813","isVote":1,"tweetType":1,"viewCount":1073,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":849595820,"gmtCreate":1635764533471,"gmtModify":1635764533471,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>[Miser]&nbsp;","text":"$Merck(MRK)$[Miser]","images":[{"img":"https://static.tigerbbs.com/4731e1124d23dd6dbf40f6112c0fdb03","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849595820","isVote":1,"tweetType":1,"viewCount":727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":852143881,"gmtCreate":1635255500813,"gmtModify":1635255500926,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[Miser]&nbsp;","text":"$Apple(AAPL)$[Miser]","images":[{"img":"https://static.tigerbbs.com/514007d28a9428696b15cb3cc055cc9f","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852143881","isVote":1,"tweetType":1,"viewCount":863,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":859041055,"gmtCreate":1634644455710,"gmtModify":1634644455875,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NFLX\">$Netflix(NFLX)$</a>[Cool]&nbsp;","listText":"<a href=\"https://laohu8.com/S/NFLX\">$Netflix(NFLX)$</a>[Cool]&nbsp;","text":"$Netflix(NFLX)$[Cool]","images":[{"img":"https://static.tigerbbs.com/81c6da67fb7138c034062f1c3811bc0c","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859041055","isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":838175937,"gmtCreate":1629383149829,"gmtModify":1631886967717,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JNJ\">$Johnson &amp; Johnson(JNJ)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/JNJ\">$Johnson &amp; Johnson(JNJ)$</a>[Miser]&nbsp;","text":"$Johnson & Johnson(JNJ)$[Miser]","images":[{"img":"https://static.tigerbbs.com/98019dcdc702cafb7bfac8210c2c76b2","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/838175937","isVote":1,"tweetType":1,"viewCount":4,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898433977,"gmtCreate":1628516528699,"gmtModify":1631888778662,"author":{"id":"4088337047102210","authorId":"4088337047102210","name":"PP_July","avatar":"https://static.tigerbbs.com/21aefc37510e26b85253584fcd0c461f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088337047102210","authorIdStr":"4088337047102210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NARI\">$Inari Medical, Inc.(NARI)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/NARI\">$Inari Medical, Inc.(NARI)$</a>[Miser]&nbsp;","text":"$Inari Medical, Inc.(NARI)$[Miser]","images":[{"img":"https://static.tigerbbs.com/d5f3698de05fee1af270cc9aa1ab9956","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/898433977","isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}